Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven A.J. Salamon, and Aharon Gil filed Amendment No. 10 to Schedule 13G with the SEC on November 13, 2026, disclosing their beneficial ownership position in MediWound Ltd. as of November 5, 2026.

Key Highlights

  • Aggregate beneficial ownership: Each reporting person disclosed 1,312,319 shares beneficially owned, representing 9.1% of MediWound Ltd. common shares outstanding.
  • Share composition: The reported position includes 1,149,054 shares of common stock and 163,265 shares issuable upon exercise of warrants.
  • Blocker provision applies: According to the filing, the warrant holder does not have the right to exercise warrants to the extent such exercise would result in beneficial ownership exceeding 9.99% of common stock, so actual shares owned after giving effect to the blocker are less than the reported total.
  • Shares outstanding basis: The 9.1% percentage is calculated based upon 14,210,217 shares outstanding as of November 5, 2026, per the issuer's 424B5 prospectus filed that date.
  • Voting and dispositive power: All four reporting persons report zero sole voting or dispositive power; shared voting and dispositive power are each reported as 1,312,319 shares at the cover-page level, and 1,149,054 shares in Item 4(c).
  • Beneficial ownership disclaimer: The filing states that Rosalind Advisors, Inc. and Steven Salamon "disclaim beneficial ownership of the shares."

Rosalind Group's MediWound Position: Amendment No. 10 Details

The four reporting persons - Rosalind Advisors, Inc. (organized in Ontario, Canada), Rosalind Master Fund L.P. (organized in the Cayman Islands), Steven A.J. Salamon, and Aharon Gil - filed this amendment jointly. According to the filing, Rosalind Advisors, Inc. serves as investment advisor to Rosalind Master Fund L.P. Steven Salamon is identified as portfolio manager of the Advisor, and Gilad Aharon is described as "the portfolio manager and member of the Advisor which advises RMF."

The filing reports that Rosalind Master Fund L.P. may be deemed to beneficially own 1,149,054 shares of common stock, representing approximately 8.09% of the common stock, when excluding the 163,265 warrant shares blocked by the 9.99% ownership cap provision. The aggregate figure of 1,312,319 shown on the cover pages reflects full conversion and exercise of all reported securities without regard to the blocker, as the filing explicitly notes that "the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported."

The securities are described in the filing as acquired and held in the ordinary course of business. MediWound Ltd. is an Israeli company with principal offices listed at 42 Hayarkon Street, Yavne, Israel. The filing does not name an exchange or ticker symbol for MediWound in its text.

What Was Disclosed

Rosalind Advisors and affiliated persons filed Amendment No. 10 to Schedule 13G reporting a 9.1% beneficial ownership stake in MediWound Ltd. common shares as of November 5, 2026, comprised of 1,149,054 direct shares and 163,265 warrant-linked shares subject to a 9.99% blocker.